Northern Antibiotics Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 1
Employees
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Northern Antibiotics General Information

Description

Operator of an antibiotic development company intended to develop novel compounds for treating gram-negative bacteria. The company's compounds are antibacterial and include a compound with activity against pseudomonas aeruginosa and also sensitizes gram-negative enteric bacteria and acinetobacter to the action of antibiotics usually used for the treatment of gram-positive infections, enabling physicians to treat in an enhanced way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Tekniikantie 14 (Technopolis, Innopoli 2)
  • Suite A111
  • 02150 Espoo
  • Finland
+358 050 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Northern Antibiotics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view Northern Antibiotics’s complete valuation and funding history, request access »

Northern Antibiotics Executive Team (2)

Name Title Board Seat Contact Info
Martti Vaara Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Timo Vaara Co-Founder, Vice President of Business Development & Chairman
To view Northern Antibiotics’s complete executive team members history, request access »

Northern Antibiotics Board Members (3)

Name Representing Role Since
Juha Jouhki Self Board Member 000 0000
Martti Hintikka Self Board Member 000 0000
Martti Vaara Ph.D Northern Antibiotics Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
To view Northern Antibiotics’s complete board members history, request access »

Northern Antibiotics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Northern Antibiotics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innofinance Venture Capital Minority 000 0000 000000 0
To view Northern Antibiotics’s complete investors history, request access »